CUE vs NIO · rev $13.6M vs rev $12.51B
Cue Biopharma (CUE) versus Nio Inc Class A ADR (NIO) — a side-by-side from cached financials, not a winner call.
Cue Biopharma (CUE) is a biotechnology company listed on US.
Nio Inc Class A ADR (NIO) is a auto manufacturers company listed on US.
Latest reported CUE revenue for 2026-06-30 was $13.6M. Net income was -$158.2M. CUE currently screens at market cap $59.5M.
Latest reported NIO revenue for 2025-12-31 was $12.51B. Net income was -$2.14B. Revenue was up 38.9% from 2024-12-31 to 2025-12-31. NIO currently screens at market cap $7.61B.
CUE currently screens at market cap $59.5M. NIO currently screens at market cap $7.61B.
Not investment advice. Open the CUE and NIO stock pages for the full models.
Not investment advice.